XBP Global Q3 Revenue Falls 12.6%, Books $147.5M TCV
AiX — Free Expert Advisor
Trades XAUUSD on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. AiX is informational software — not investment advice. Past performance does not guarantee future results.
XBP Global Holdings, Inc. (NASDAQ: XBP) reported third-quarter 2026 revenue of $182.8 million on November 16, 2026, a decline of 12.6% year-over-year as reported and 17.1% on a pro forma basis, with a net loss of $89.0 million that included a $68.4 million goodwill impairment charge. Normalized EBITDA of $22.6 million produced a 12.4% margin, the company said, up 120 basis points year-over-year on a pro forma basis and the highest for the combined company since the July 2025 combination.
Context — Why XBP Global's Revenue Decline Matters Now
XBP Global is a multinational technology and services company that orchestrates mission-critical systems for hyper-automation and digital transformation. The company operates in 20 countries with roughly 8,100 employees and more than 2,000 clients, including many Fortune 100 names, according to the report. That scale makes the quarterly print a read on enterprise spending on applied AI and workflow automation, particularly in regulated industries.
The revenue decline is not a demand shock. The company attributed it to the planned run-off of restructuring-related client exits that began last year, a process management said it anticipated. The comparison base is also complicated by accounting: BPA is treated as the accounting acquirer in the July 2025 combination, and reported results exclude XBP Europe until July 31, 2025. Pro forma figures restate both periods as if the BPA acquisition closed on January 1, 2025.
What changed this quarter is the commercial side. XBP closed $147.5 million of total contract value bookings, up 204.8% year-over-year and 53.9% above the trailing four-quarter average. New annual contract value bookings reached $37.5 million, up 103.7% year-over-year. Chief Executive Andrej Jonovic called it the strongest bookings quarter since the combination.
Margin expansion is running alongside the revenue decline. Gross margin reached 23.5%, up 150 basis points year-over-year as reported and 160 basis points pro forma. Adjusted gross margin hit 24.4%. The company also raised its targeted annualized operational efficiencies to $70 million to $75 million, from $65 million to $75 million previously, and continues to expect roughly $35 million of in-year benefit in 2026.
Data — What the Numbers Show
The headline figures frame a company trading revenue for margin and bookings. Revenue of $182.8 million fell 4.5% sequentially, on top of the 12.6% year-over-year decline. Net loss of $89.0 million compared with a net loss of $305.8 million in the successor period from August 1 to September 30, 2025, though that earlier figure carried a $295.8 million goodwill impairment.
| Metric | Q3 2026 | Change |
|---|---|---|
| Revenue | $182.8M | -12.6% YoY, -4.5% QoQ |
| Gross margin | 23.5% | +150 bps YoY |
| Adjusted gross margin | 24.4% | +180 bps YoY pro forma |
| Normalized EBITDA | $22.6M | -8.5% YoY pro forma |
| Normalized EBITDA margin | 12.4% | +120 bps YoY pro forma |
| Total TCV bookings | $147.5M | +204.8% YoY |
| New ACV bookings | $37.5M | +103.7% YoY |
On the balance sheet, cash and cash equivalents fell to $28.7 million from $37.1 million at December 31, 2025, while restricted cash dropped to $9.9 million from $31.6 million. Goodwill declined to $121.5 million from $189.9 million, reflecting the impairment. Total stockholders' equity swung to a deficit of $38.3 million from positive $87.3 million at year-end 2025, driven by the accumulated deficit widening to $483.6 million from $351.1 million.
Long-term debt net of current maturities stood at $351.6 million, down modestly from $353.3 million. Subsequent to quarter end, the company repaid the full $6.5 million Second Lien Note at maturity on October 1, 2026 and the remaining $0.5 million under the Amended BR Exar AR Facility, reducing debt by roughly $7.0 million. The company also completed a private placement of approximately 2.3 million shares for gross proceeds of about $6.1 million, with participation from existing shareholders, directors and affiliates.
Analysis — What It Means for Markets and Sectors
The bookings-to-revenue gap is the central tension. XBP booked $147.5 million of TCV in one quarter against $182.8 million of recognized revenue, and Jonovic said new TCV in the first nine months of 2026 already exceeded the full-year 2025 total. If that backlog converts, the revenue trajectory inflects. If it does not, the company keeps shrinking while carrying $351.6 million of long-term debt and a negative equity position.
Investors should treat TCV and ACV carefully. The company defines TCV as initial estimated revenue from contracts signed in the period without regard for early termination or revenue recognition rules, and warns that amounts ultimately recognized as revenue may differ because of contract modifications, terminations, performance obligations and other factors. Bookings are an operating metric, not a revenue substitute.
The impairment is the clearest signal of the risk. A $68.4 million goodwill write-down in the quarter, following a $295.8 million impairment in the prior-year successor period, indicates the carrying value of acquired businesses has repeatedly needed resetting. That pattern matters for anyone tracking the July 2025 combination and its accounting.
Sector exposure runs through IT services and enterprise automation, where demand is shifting toward applied AI deployed inside client environments with human oversight. The company said it sees that demand strongest in healthcare, financial services and the public sector. Those are long sales cycles with heavy compliance review, which explains why bookings lead revenue rather than tracking it.
Positioning reflects the split. The private placement drew existing shareholders, directors and affiliates, a sign insiders absorbed dilution rather than let it clear in the market. The $6.1 million raised is small against the equity deficit, so the balance sheet remains the swing factor. Bears point to revenue still falling and equity below zero; bulls point to the highest normalized EBITDA margin for the combined company and record bookings.
Outlook — What to Watch Next
Management guided for fourth-quarter revenue to increase sequentially, and said the priority is reaching the point where new business more than offsets the run-off. That sequential turn is the first checkpoint. The second is conversion: whether the $147.5 million of TCV and $37.5 million of new ACV begin showing up in reported revenue rather than staying in the backlog.
The operational efficiency program is the third lever. The company raised its target to $70 million to $75 million of annualized efficiencies and expects about $35 million of in-year benefit in 2026, so the pace of realized savings against that target is measurable each quarter. Margin, not revenue, has been the reliable line.
Debt remains the constraint to monitor. After the roughly $7.0 million of post-quarter repayments, $351.6 million of long-term debt still sits against $28.7 million of cash. Any further equity raises would dilute holders of the 14,198,379 shares outstanding as of September 30, 2026. The company did not disclose terms of the private placement beyond gross proceeds and participant categories.
Frequently Asked Questions
What does XBP Global's Q3 2026 net loss actually reflect?
The $89.0 million net loss includes a $68.4 million non-cash goodwill impairment charge. Excluding that and other adjustments, normalized EBITDA was positive at $22.6 million. The company also recorded $15.5 million of net interest expense and $14.9 million of depreciation and amortization in the quarter. The loss is therefore driven largely by write-downs and financing costs rather than by cash operating losses at the EBITDA line.
Why did XBP Global's revenue fall while bookings rose?
Revenue recognizes over time as contracts are delivered, while TCV captures the estimated total value of contracts signed in the period. The revenue decline stems from client exits tied to restructuring that began last year and are running off as planned. Bookings reflect new and expanded contracts that have not yet converted. The gap between the two is the timing difference management is trying to close.
Trade XAUUSD on autopilot — free Expert Advisor
AiX is our free MetaTrader 5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. XAUUSD breakout engine.
PartnerTrade 800+ global stocks & ETFs
Start TradingSponsored
Ready to trade the markets?
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.